Skip to main content
Premium Trial:

Request an Annual Quote

PreventionGenetics to Use GoldenHelix's VarSeq for Dx Test Offering

NEW YORK (GenomeWeb) – Golden Helix has signed an agreement with PreventionGenetics that allows the latter to implement Golden Helix's VarSeq software into its exome sequencing pipeline.

PreventionGenetics will use the solution to analyze data from an exome sequencing test for clinical diagnostics that the company is preparing to launch in mid-2015. The software streamlines the process of annotating and filtering variants from next-generation sequencing data. It features a simple user interface and scalable architecture with repeatable workflows, tools for note taking and reporting, and filter parameter prototyping.

VarSeq "will allow us to move forward with offering an exome test" by providing tools "to take abundant sequence from exome data and efficiently translate that into molecular diagnoses," Jerry Machado, a clinical molecular geneticist at PreventionGenetics, said in a statement.

Financial and other terms of the agreement were not disclosed.


The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.